Peptide modification is how a linear sequence becomes an assay reagent: a biotinylated bait, a fluorescent probe, a PEGylated analogue or a cyclic binder. ChinaPeptides treats modification as part of custom peptide synthesis, not as a sticker applied after the fact.
The request should name the chemistry, the residue or terminus, any spacer, and the detection or conjugation method. Those four items determine whether the label survives cleavage and whether the peptide remains soluble enough to purify.
N-terminal and C-terminal modification
Acetylation is the most common N-terminal cap. Fatty-acid and other acyl groups are used when membrane association is part of the study. C-terminal amidation is requested when the native peptide is an amide or when a free carboxylate would change charge. Esters and functionalized C-termini are evaluated case by case.
Acetylation and amidation look like small checkboxes on a form and they are not. An acetylated N-terminus removes a charge that a protease, an HPLC method and a mass calculation all see. An amide at the C-terminus changes the molecular weight by −1 Da relative to the free acid and is the native form of many endocrine and neuropeptide sequences. If you copy a literature sequence, copy the termini as well. Custom peptide modification starts with that pair of decisions, then adds labels.
Biotinylation, PEGylation and phosphorylation
Biotin (with or without an Ahx or PEG spacer) supports streptavidin capture. PEGylation is used to change hydrodynamic size or reduce non-specific binding in vitro. Phosphopeptides on Ser, Thr or Tyr are prepared for kinase and phosphatase work; we confirm that the phospho group is compatible with the purification pH.
Design notes for biotin and PEG are expanded in biotinylated peptides and peptide PEGylation.
Fluorescent labeling and FRET
FITC, 5-FAM, TAMRA, Cy3 and Cy5 are the dyes we discuss most often. Placement is usually the N-terminus or a dedicated lysine, with a spacer when the dye would otherwise quench or interfere with binding. FRET peptides need a matched donor–acceptor pair and a cleavage or conformational sequence specified by the user. See fluorescent peptides and FITC vs TAMRA vs Cy5.
Lipidation, cyclization and isotope labels
Palmitoyl and myristoyl groups are typical lipidations. Cyclization may be a disulfide, a lactam or a head-to-tail amide; methods are compared in disulfide vs head-to-tail cyclization and on the cyclic peptides page. Stable-isotope residues are introduced for mass-spectrometry quantitation when the labeled amino acids are available for the requested positions.
Linkers, protein conjugation and click chemistry
Ahx, short PEG and cleavable linkers are used to distance a label from the epitope. Protein conjugation (KLH, BSA, OVA) is aligned with antigen design and antibody programs. Azide/alkyne click handles support later conjugation in the customer laboratory.
Click chemistry is useful when the peptide must stay unmodified through purification and the cargo is attached later. It is the wrong tool when you already know the final conjugate and can make it in one project. Name the handle (azide, alkyne, cysteine, maleimide) and the cargo so we do not install two competing reactive groups. Peptide labeling and peptide conjugation are related but not identical: a dye on lysine is a labeling project; KLH on a C-terminal cysteine is a conjugation project. Both belong on this page because the synthesis route has to know about them before the first residue is loaded.
Phosphorylation, lipidation and staples each add a purification constraint. A phosphopeptide can lose phosphate in harsh cleavage; a lipopeptide can stick to plastic and to reversed-phase columns; a staple changes both mass and HPLC retention. Those are reasons to read the comparison table and the supporting articles rather than stacking every modification on one short peptide “because the catalog of options exists.”
Modification comparison
| Modification | Typical position | Research purpose | Compatible scale |
|---|---|---|---|
| Acetylation | N-terminus or Lys | Charge and protease studies | mg–g |
| Amidation | C-terminus | Mimic native C-terminal amides | mg–g |
| Biotinylation | N-terminus, Lys or Cys handle | Pull-down and immobilization | mg–g |
| PEGylation | N-terminus or Lys | Solubility and size studies | mg–multi-g |
| Phosphorylation | Ser, Thr, Tyr | Signaling and kinase work | mg–g |
| FITC / TAMRA / Cy3 / Cy5 | N-terminus or Lys | Imaging and binding assays | mg |
| FRET pair | Two specified sites | Protease and conformational assays | mg |
| Lipidation | N-terminus or Lys | Membrane and adjuvant research | mg–g |
| Cyclization | Cys–Cys or termini | Conformational constraint | mg–g |
| Isotope labeling | Selected residues | MS quantitation | mg |
| Protein conjugation | Carrier protein | Immunization research | mg |
| Click handle | N-terminus or Lys | Bioorthogonal conjugation | mg–g |
Quality documentation for labeled lots follows the same HPLC and LC-MS path described under peptide quality control. Dye and lipid lots can show additional peaks; we discuss those before you lock a purity number.
Frequently asked questions
When should a modification be planned versus added later?
Labels, cyclization and conjugation handles should be designed with the synthesis route. Adding a dye after a poorly soluble sequence is assembled often costs more than placing a spacer during SPPS.
Which fluorescent dye should I choose?
FITC and 5-FAM are common for routine detection. TAMRA is used when a longer-wavelength rhodamine is preferred. Cy3 and Cy5 suit multiplex imaging. See the fluorescent peptide and dye-comparison articles for optical constraints.
Can you biotinylate and PEGylate the same peptide?
Often yes, if the two sites are specified (for example N-terminal biotin and a Lys-PEG). Site conflict is the usual reason a dual-label request is redesigned.
Do you offer click-chemistry handles?
Azide and alkyne handles can be introduced when the residue and spacer are defined. We review copper-catalyzed versus strain-promoted options against the intended assay.
Is protein conjugation included?
KLH, BSA and OVA conjugation are available for antigenic peptides used in antibody research. The peptide is synthesized and purified before coupling.
Are modified peptides for clinical use?
No. Modified peptides from this service are research materials only.
